nodes	percent_of_prediction	percent_of_DWPC	metapath
Gatifloxacin—Injection site reaction—Doxorubicin—muscle cancer	0.00418	0.00418	CcSEcCtD
Gatifloxacin—Myalgia—Dactinomycin—muscle cancer	0.00417	0.00417	CcSEcCtD
Gatifloxacin—Lymphadenopathy—Methotrexate—muscle cancer	0.00414	0.00414	CcSEcCtD
Gatifloxacin—Diabetes mellitus—Methotrexate—muscle cancer	0.00406	0.00406	CcSEcCtD
Gatifloxacin—Colitis—Doxorubicin—muscle cancer	0.00404	0.00404	CcSEcCtD
Gatifloxacin—Agitation—Vincristine—muscle cancer	0.00402	0.00402	CcSEcCtD
Gatifloxacin—Photosensitivity—Methotrexate—muscle cancer	0.00402	0.00402	CcSEcCtD
Gatifloxacin—Candida infection—Doxorubicin—muscle cancer	0.00402	0.00402	CcSEcCtD
Gatifloxacin—Oedema—Dactinomycin—muscle cancer	0.004	0.004	CcSEcCtD
Gatifloxacin—Fluid retention—Doxorubicin—muscle cancer	0.004	0.004	CcSEcCtD
Gatifloxacin—Infection—Dactinomycin—muscle cancer	0.00397	0.00397	CcSEcCtD
Gatifloxacin—Vaginal infection—Doxorubicin—muscle cancer	0.00397	0.00397	CcSEcCtD
Gatifloxacin—Vertigo—Vincristine—muscle cancer	0.00393	0.00393	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Dactinomycin—muscle cancer	0.00392	0.00392	CcSEcCtD
Gatifloxacin—Dry eye—Doxorubicin—muscle cancer	0.00389	0.00389	CcSEcCtD
Gatifloxacin—Cramps of lower extremities—Doxorubicin—muscle cancer	0.00387	0.00387	CcSEcCtD
Gatifloxacin—Erythema multiforme—Etoposide—muscle cancer	0.00385	0.00385	CcSEcCtD
Gatifloxacin—Rash maculo-papular—Doxorubicin—muscle cancer	0.00383	0.00383	CcSEcCtD
Gatifloxacin—Renal failure acute—Methotrexate—muscle cancer	0.00382	0.00382	CcSEcCtD
Gatifloxacin—Anorexia—Dactinomycin—muscle cancer	0.00381	0.00381	CcSEcCtD
Gatifloxacin—Eye disorder—Etoposide—muscle cancer	0.00381	0.00381	CcSEcCtD
Gatifloxacin—Mouth ulceration—Doxorubicin—muscle cancer	0.00381	0.00381	CcSEcCtD
Gatifloxacin—Ecchymosis—Doxorubicin—muscle cancer	0.00381	0.00381	CcSEcCtD
Gatifloxacin—Convulsion—Vincristine—muscle cancer	0.00379	0.00379	CcSEcCtD
Gatifloxacin—Hypertension—Vincristine—muscle cancer	0.00378	0.00378	CcSEcCtD
Gatifloxacin—Myalgia—Vincristine—muscle cancer	0.00373	0.00373	CcSEcCtD
Gatifloxacin—Hypertonia—Doxorubicin—muscle cancer	0.00369	0.00369	CcSEcCtD
Gatifloxacin—Abnormal vision—Doxorubicin—muscle cancer	0.00367	0.00367	CcSEcCtD
Gatifloxacin—Chills—Etoposide—muscle cancer	0.00366	0.00366	CcSEcCtD
Gatifloxacin—Mental disability—Doxorubicin—muscle cancer	0.00365	0.00365	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00364	0.00364	CcSEcCtD
Gatifloxacin—Lymphadenopathy—Doxorubicin—muscle cancer	0.00358	0.00358	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Vincristine—muscle cancer	0.00357	0.00357	CcSEcCtD
Gatifloxacin—Oedema—Vincristine—muscle cancer	0.00357	0.00357	CcSEcCtD
Gatifloxacin—Infection—Vincristine—muscle cancer	0.00355	0.00355	CcSEcCtD
Gatifloxacin—Diabetes mellitus—Doxorubicin—muscle cancer	0.00351	0.00351	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Vincristine—muscle cancer	0.0035	0.0035	CcSEcCtD
Gatifloxacin—Photosensitivity—Doxorubicin—muscle cancer	0.00348	0.00348	CcSEcCtD
Gatifloxacin—Decreased appetite—Dactinomycin—muscle cancer	0.00348	0.00348	CcSEcCtD
Gatifloxacin—Dysgeusia—Etoposide—muscle cancer	0.00347	0.00347	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Vincristine—muscle cancer	0.00345	0.00345	CcSEcCtD
Gatifloxacin—Back pain—Etoposide—muscle cancer	0.00343	0.00343	CcSEcCtD
Gatifloxacin—Muscle spasms—Etoposide—muscle cancer	0.00341	0.00341	CcSEcCtD
Gatifloxacin—Anorexia—Vincristine—muscle cancer	0.00341	0.00341	CcSEcCtD
Gatifloxacin—Eye pain—Doxorubicin—muscle cancer	0.00338	0.00338	CcSEcCtD
Gatifloxacin—Hypotension—Vincristine—muscle cancer	0.00334	0.00334	CcSEcCtD
Gatifloxacin—Ataxia—Methotrexate—muscle cancer	0.00332	0.00332	CcSEcCtD
Gatifloxacin—Renal failure acute—Doxorubicin—muscle cancer	0.00331	0.00331	CcSEcCtD
Gatifloxacin—Feeling abnormal—Dactinomycin—muscle cancer	0.0033	0.0033	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00327	0.00327	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00326	0.00326	CcSEcCtD
Gatifloxacin—Insomnia—Vincristine—muscle cancer	0.00323	0.00323	CcSEcCtD
Gatifloxacin—Renal impairment—Doxorubicin—muscle cancer	0.00321	0.00321	CcSEcCtD
Gatifloxacin—Paraesthesia—Vincristine—muscle cancer	0.00321	0.00321	CcSEcCtD
Gatifloxacin—Dermatitis bullous—Doxorubicin—muscle cancer	0.0032	0.0032	CcSEcCtD
Gatifloxacin—Vertigo—Etoposide—muscle cancer	0.00319	0.00319	CcSEcCtD
Gatifloxacin—Abdominal pain—Dactinomycin—muscle cancer	0.00316	0.00316	CcSEcCtD
Gatifloxacin—Body temperature increased—Dactinomycin—muscle cancer	0.00316	0.00316	CcSEcCtD
Gatifloxacin—Hypoglycaemia—Doxorubicin—muscle cancer	0.00313	0.00313	CcSEcCtD
Gatifloxacin—Loss of consciousness—Etoposide—muscle cancer	0.00312	0.00312	CcSEcCtD
Gatifloxacin—Decreased appetite—Vincristine—muscle cancer	0.00311	0.00311	CcSEcCtD
Gatifloxacin—Convulsion—Etoposide—muscle cancer	0.00307	0.00307	CcSEcCtD
Gatifloxacin—Hypertension—Etoposide—muscle cancer	0.00306	0.00306	CcSEcCtD
Gatifloxacin—Constipation—Vincristine—muscle cancer	0.00306	0.00306	CcSEcCtD
Gatifloxacin—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.00306	0.00306	CcSEcCtD
Gatifloxacin—Asthma—Methotrexate—muscle cancer	0.00305	0.00305	CcSEcCtD
Gatifloxacin—Chest pain—Etoposide—muscle cancer	0.00302	0.00302	CcSEcCtD
Gatifloxacin—Migraine—Doxorubicin—muscle cancer	0.00301	0.00301	CcSEcCtD
Gatifloxacin—Pancreatitis—Methotrexate—muscle cancer	0.00299	0.00299	CcSEcCtD
Gatifloxacin—Face oedema—Doxorubicin—muscle cancer	0.00295	0.00295	CcSEcCtD
Gatifloxacin—Hypersensitivity—Dactinomycin—muscle cancer	0.00295	0.00295	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Vincristine—muscle cancer	0.00292	0.00292	CcSEcCtD
Gatifloxacin—Confusional state—Etoposide—muscle cancer	0.00292	0.00292	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Etoposide—muscle cancer	0.0029	0.0029	CcSEcCtD
Gatifloxacin—Infection—Etoposide—muscle cancer	0.00288	0.00288	CcSEcCtD
Gatifloxacin—Ataxia—Doxorubicin—muscle cancer	0.00287	0.00287	CcSEcCtD
Gatifloxacin—Asthenia—Dactinomycin—muscle cancer	0.00287	0.00287	CcSEcCtD
Gatifloxacin—Neutropenia—Methotrexate—muscle cancer	0.00285	0.00285	CcSEcCtD
Gatifloxacin—Dysuria—Methotrexate—muscle cancer	0.00285	0.00285	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Etoposide—muscle cancer	0.00283	0.00283	CcSEcCtD
Gatifloxacin—Tachycardia—Etoposide—muscle cancer	0.00283	0.00283	CcSEcCtD
Gatifloxacin—Abdominal pain—Vincristine—muscle cancer	0.00283	0.00283	CcSEcCtD
Gatifloxacin—Body temperature increased—Vincristine—muscle cancer	0.00283	0.00283	CcSEcCtD
Gatifloxacin—Dry skin—Doxorubicin—muscle cancer	0.0028	0.0028	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Etoposide—muscle cancer	0.0028	0.0028	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Methotrexate—muscle cancer	0.00278	0.00278	CcSEcCtD
Gatifloxacin—Anorexia—Etoposide—muscle cancer	0.00276	0.00276	CcSEcCtD
Gatifloxacin—Diarrhoea—Dactinomycin—muscle cancer	0.00274	0.00274	CcSEcCtD
Gatifloxacin—Nasopharyngitis—Doxorubicin—muscle cancer	0.00273	0.00273	CcSEcCtD
Gatifloxacin—Hypotension—Etoposide—muscle cancer	0.00271	0.00271	CcSEcCtD
Gatifloxacin—Gastritis—Doxorubicin—muscle cancer	0.0027	0.0027	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.0027	0.0027	CcSEcCtD
Gatifloxacin—Muscular weakness—Doxorubicin—muscle cancer	0.00269	0.00269	CcSEcCtD
Gatifloxacin—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00269	0.00269	CcSEcCtD
Gatifloxacin—Stomatitis—Methotrexate—muscle cancer	0.00265	0.00265	CcSEcCtD
Gatifloxacin—Conjunctivitis—Methotrexate—muscle cancer	0.00264	0.00264	CcSEcCtD
Gatifloxacin—Asthma—Doxorubicin—muscle cancer	0.00264	0.00264	CcSEcCtD
Gatifloxacin—Dysphagia—Doxorubicin—muscle cancer	0.00264	0.00264	CcSEcCtD
Gatifloxacin—Hypersensitivity—Vincristine—muscle cancer	0.00263	0.00263	CcSEcCtD
Gatifloxacin—Sweating—Methotrexate—muscle cancer	0.00261	0.00261	CcSEcCtD
Gatifloxacin—Paraesthesia—Etoposide—muscle cancer	0.0026	0.0026	CcSEcCtD
Gatifloxacin—Haematuria—Methotrexate—muscle cancer	0.00259	0.00259	CcSEcCtD
Gatifloxacin—Pancreatitis—Doxorubicin—muscle cancer	0.00259	0.00259	CcSEcCtD
Gatifloxacin—Dyspnoea—Etoposide—muscle cancer	0.00258	0.00258	CcSEcCtD
Gatifloxacin—Somnolence—Etoposide—muscle cancer	0.00257	0.00257	CcSEcCtD
Gatifloxacin—Epistaxis—Methotrexate—muscle cancer	0.00256	0.00256	CcSEcCtD
Gatifloxacin—Asthenia—Vincristine—muscle cancer	0.00256	0.00256	CcSEcCtD
Gatifloxacin—Vomiting—Dactinomycin—muscle cancer	0.00254	0.00254	CcSEcCtD
Gatifloxacin—Rash—Dactinomycin—muscle cancer	0.00252	0.00252	CcSEcCtD
Gatifloxacin—Decreased appetite—Etoposide—muscle cancer	0.00252	0.00252	CcSEcCtD
Gatifloxacin—Constipation—Etoposide—muscle cancer	0.00248	0.00248	CcSEcCtD
Gatifloxacin—Dysuria—Doxorubicin—muscle cancer	0.00247	0.00247	CcSEcCtD
Gatifloxacin—Neutropenia—Doxorubicin—muscle cancer	0.00247	0.00247	CcSEcCtD
Gatifloxacin—Diarrhoea—Vincristine—muscle cancer	0.00245	0.00245	CcSEcCtD
Gatifloxacin—Hepatitis—Methotrexate—muscle cancer	0.00244	0.00244	CcSEcCtD
Gatifloxacin—Pharyngitis—Methotrexate—muscle cancer	0.00242	0.00242	CcSEcCtD
Gatifloxacin—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00241	0.00241	CcSEcCtD
Gatifloxacin—Feeling abnormal—Etoposide—muscle cancer	0.00239	0.00239	CcSEcCtD
Gatifloxacin—Hyperglycaemia—Doxorubicin—muscle cancer	0.00238	0.00238	CcSEcCtD
Gatifloxacin—Nausea—Dactinomycin—muscle cancer	0.00238	0.00238	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Etoposide—muscle cancer	0.00237	0.00237	CcSEcCtD
Gatifloxacin—Dizziness—Vincristine—muscle cancer	0.00236	0.00236	CcSEcCtD
Gatifloxacin—Visual impairment—Methotrexate—muscle cancer	0.00235	0.00235	CcSEcCtD
Gatifloxacin—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00233	0.00233	CcSEcCtD
Gatifloxacin—Erythema multiforme—Methotrexate—muscle cancer	0.00231	0.00231	CcSEcCtD
Gatifloxacin—Urticaria—Etoposide—muscle cancer	0.0023	0.0023	CcSEcCtD
Gatifloxacin—Stomatitis—Doxorubicin—muscle cancer	0.00229	0.00229	CcSEcCtD
Gatifloxacin—Abdominal pain—Etoposide—muscle cancer	0.00229	0.00229	CcSEcCtD
Gatifloxacin—Body temperature increased—Etoposide—muscle cancer	0.00229	0.00229	CcSEcCtD
Gatifloxacin—Conjunctivitis—Doxorubicin—muscle cancer	0.00229	0.00229	CcSEcCtD
Gatifloxacin—Eye disorder—Methotrexate—muscle cancer	0.00228	0.00228	CcSEcCtD
Gatifloxacin—Tinnitus—Methotrexate—muscle cancer	0.00228	0.00228	CcSEcCtD
Gatifloxacin—Vomiting—Vincristine—muscle cancer	0.00227	0.00227	CcSEcCtD
Gatifloxacin—Sweating—Doxorubicin—muscle cancer	0.00226	0.00226	CcSEcCtD
Gatifloxacin—Rash—Vincristine—muscle cancer	0.00225	0.00225	CcSEcCtD
Gatifloxacin—Dermatitis—Vincristine—muscle cancer	0.00225	0.00225	CcSEcCtD
Gatifloxacin—Haematuria—Doxorubicin—muscle cancer	0.00224	0.00224	CcSEcCtD
Gatifloxacin—Headache—Vincristine—muscle cancer	0.00224	0.00224	CcSEcCtD
Gatifloxacin—Epistaxis—Doxorubicin—muscle cancer	0.00222	0.00222	CcSEcCtD
Gatifloxacin—Chills—Methotrexate—muscle cancer	0.00219	0.00219	CcSEcCtD
Gatifloxacin—Bradycardia—Doxorubicin—muscle cancer	0.00215	0.00215	CcSEcCtD
Gatifloxacin—Hypersensitivity—Etoposide—muscle cancer	0.00213	0.00213	CcSEcCtD
Gatifloxacin—Erythema—Methotrexate—muscle cancer	0.00212	0.00212	CcSEcCtD
Gatifloxacin—Nausea—Vincristine—muscle cancer	0.00212	0.00212	CcSEcCtD
Gatifloxacin—Hepatitis—Doxorubicin—muscle cancer	0.00211	0.00211	CcSEcCtD
Gatifloxacin—Pharyngitis—Doxorubicin—muscle cancer	0.0021	0.0021	CcSEcCtD
Gatifloxacin—Oedema peripheral—Doxorubicin—muscle cancer	0.00208	0.00208	CcSEcCtD
Gatifloxacin—Dysgeusia—Methotrexate—muscle cancer	0.00208	0.00208	CcSEcCtD
Gatifloxacin—Asthenia—Etoposide—muscle cancer	0.00208	0.00208	CcSEcCtD
Gatifloxacin—Back pain—Methotrexate—muscle cancer	0.00206	0.00206	CcSEcCtD
Gatifloxacin—Pruritus—Etoposide—muscle cancer	0.00205	0.00205	CcSEcCtD
Gatifloxacin—Visual impairment—Doxorubicin—muscle cancer	0.00204	0.00204	CcSEcCtD
Gatifloxacin—Vision blurred—Methotrexate—muscle cancer	0.002	0.002	CcSEcCtD
Gatifloxacin—Erythema multiforme—Doxorubicin—muscle cancer	0.002	0.002	CcSEcCtD
Gatifloxacin—Diarrhoea—Etoposide—muscle cancer	0.00198	0.00198	CcSEcCtD
Gatifloxacin—Eye disorder—Doxorubicin—muscle cancer	0.00198	0.00198	CcSEcCtD
Gatifloxacin—Tinnitus—Doxorubicin—muscle cancer	0.00197	0.00197	CcSEcCtD
Gatifloxacin—Dizziness—Etoposide—muscle cancer	0.00191	0.00191	CcSEcCtD
Gatifloxacin—Vertigo—Methotrexate—muscle cancer	0.00191	0.00191	CcSEcCtD
Gatifloxacin—Chills—Doxorubicin—muscle cancer	0.0019	0.0019	CcSEcCtD
Gatifloxacin—Convulsion—Methotrexate—muscle cancer	0.00184	0.00184	CcSEcCtD
Gatifloxacin—Vomiting—Etoposide—muscle cancer	0.00184	0.00184	CcSEcCtD
Gatifloxacin—Erythema—Doxorubicin—muscle cancer	0.00184	0.00184	CcSEcCtD
Gatifloxacin—Rash—Etoposide—muscle cancer	0.00183	0.00183	CcSEcCtD
Gatifloxacin—Dermatitis—Etoposide—muscle cancer	0.00182	0.00182	CcSEcCtD
Gatifloxacin—Headache—Etoposide—muscle cancer	0.00181	0.00181	CcSEcCtD
Gatifloxacin—Flatulence—Doxorubicin—muscle cancer	0.00181	0.00181	CcSEcCtD
Gatifloxacin—Myalgia—Methotrexate—muscle cancer	0.00181	0.00181	CcSEcCtD
Gatifloxacin—Chest pain—Methotrexate—muscle cancer	0.00181	0.00181	CcSEcCtD
Gatifloxacin—Arthralgia—Methotrexate—muscle cancer	0.00181	0.00181	CcSEcCtD
Gatifloxacin—Tension—Doxorubicin—muscle cancer	0.00181	0.00181	CcSEcCtD
Gatifloxacin—Dysgeusia—Doxorubicin—muscle cancer	0.0018	0.0018	CcSEcCtD
Gatifloxacin—Nervousness—Doxorubicin—muscle cancer	0.00179	0.00179	CcSEcCtD
Gatifloxacin—Back pain—Doxorubicin—muscle cancer	0.00178	0.00178	CcSEcCtD
Gatifloxacin—Muscle spasms—Doxorubicin—muscle cancer	0.00177	0.00177	CcSEcCtD
Gatifloxacin—Confusional state—Methotrexate—muscle cancer	0.00175	0.00175	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Methotrexate—muscle cancer	0.00173	0.00173	CcSEcCtD
Gatifloxacin—Vision blurred—Doxorubicin—muscle cancer	0.00173	0.00173	CcSEcCtD
Gatifloxacin—Infection—Methotrexate—muscle cancer	0.00172	0.00172	CcSEcCtD
Gatifloxacin—Nausea—Etoposide—muscle cancer	0.00172	0.00172	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Methotrexate—muscle cancer	0.0017	0.0017	CcSEcCtD
Gatifloxacin—Agitation—Doxorubicin—muscle cancer	0.00169	0.00169	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Methotrexate—muscle cancer	0.00168	0.00168	CcSEcCtD
Gatifloxacin—Vertigo—Doxorubicin—muscle cancer	0.00165	0.00165	CcSEcCtD
Gatifloxacin—Anorexia—Methotrexate—muscle cancer	0.00165	0.00165	CcSEcCtD
Gatifloxacin—Syncope—Doxorubicin—muscle cancer	0.00165	0.00165	CcSEcCtD
Gatifloxacin—Palpitations—Doxorubicin—muscle cancer	0.00163	0.00163	CcSEcCtD
Gatifloxacin—Hypotension—Methotrexate—muscle cancer	0.00162	0.00162	CcSEcCtD
Gatifloxacin—Loss of consciousness—Doxorubicin—muscle cancer	0.00162	0.00162	CcSEcCtD
Gatifloxacin—Convulsion—Doxorubicin—muscle cancer	0.00159	0.00159	CcSEcCtD
Gatifloxacin—Hypertension—Doxorubicin—muscle cancer	0.00159	0.00159	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00158	0.00158	CcSEcCtD
Gatifloxacin—Insomnia—Methotrexate—muscle cancer	0.00157	0.00157	CcSEcCtD
Gatifloxacin—Arthralgia—Doxorubicin—muscle cancer	0.00157	0.00157	CcSEcCtD
Gatifloxacin—Myalgia—Doxorubicin—muscle cancer	0.00157	0.00157	CcSEcCtD
Gatifloxacin—Chest pain—Doxorubicin—muscle cancer	0.00157	0.00157	CcSEcCtD
Gatifloxacin—Anxiety—Doxorubicin—muscle cancer	0.00156	0.00156	CcSEcCtD
Gatifloxacin—Paraesthesia—Methotrexate—muscle cancer	0.00156	0.00156	CcSEcCtD
Gatifloxacin—Dyspnoea—Methotrexate—muscle cancer	0.00155	0.00155	CcSEcCtD
Gatifloxacin—Somnolence—Methotrexate—muscle cancer	0.00154	0.00154	CcSEcCtD
Gatifloxacin—Dyspepsia—Methotrexate—muscle cancer	0.00153	0.00153	CcSEcCtD
Gatifloxacin—Confusional state—Doxorubicin—muscle cancer	0.00151	0.00151	CcSEcCtD
Gatifloxacin—Decreased appetite—Methotrexate—muscle cancer	0.00151	0.00151	CcSEcCtD
Gatifloxacin—Anaphylactic shock—Doxorubicin—muscle cancer	0.0015	0.0015	CcSEcCtD
Gatifloxacin—Oedema—Doxorubicin—muscle cancer	0.0015	0.0015	CcSEcCtD
Gatifloxacin—Infection—Doxorubicin—muscle cancer	0.00149	0.00149	CcSEcCtD
Gatifloxacin—Shock—Doxorubicin—muscle cancer	0.00148	0.00148	CcSEcCtD
Gatifloxacin—Thrombocytopenia—Doxorubicin—muscle cancer	0.00147	0.00147	CcSEcCtD
Gatifloxacin—Tachycardia—Doxorubicin—muscle cancer	0.00147	0.00147	CcSEcCtD
Gatifloxacin—Hyperhidrosis—Doxorubicin—muscle cancer	0.00145	0.00145	CcSEcCtD
Gatifloxacin—Anorexia—Doxorubicin—muscle cancer	0.00143	0.00143	CcSEcCtD
Gatifloxacin—Feeling abnormal—Methotrexate—muscle cancer	0.00143	0.00143	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Methotrexate—muscle cancer	0.00142	0.00142	CcSEcCtD
Gatifloxacin—Hypotension—Doxorubicin—muscle cancer	0.0014	0.0014	CcSEcCtD
Gatifloxacin—Urticaria—Methotrexate—muscle cancer	0.00138	0.00138	CcSEcCtD
Gatifloxacin—Body temperature increased—Methotrexate—muscle cancer	0.00137	0.00137	CcSEcCtD
Gatifloxacin—Abdominal pain—Methotrexate—muscle cancer	0.00137	0.00137	CcSEcCtD
Gatifloxacin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00137	0.00137	CcSEcCtD
Gatifloxacin—Insomnia—Doxorubicin—muscle cancer	0.00136	0.00136	CcSEcCtD
Gatifloxacin—Paraesthesia—Doxorubicin—muscle cancer	0.00135	0.00135	CcSEcCtD
Gatifloxacin—Dyspnoea—Doxorubicin—muscle cancer	0.00134	0.00134	CcSEcCtD
Gatifloxacin—Somnolence—Doxorubicin—muscle cancer	0.00133	0.00133	CcSEcCtD
Gatifloxacin—Dyspepsia—Doxorubicin—muscle cancer	0.00132	0.00132	CcSEcCtD
Gatifloxacin—Decreased appetite—Doxorubicin—muscle cancer	0.00131	0.00131	CcSEcCtD
Gatifloxacin—Constipation—Doxorubicin—muscle cancer	0.00128	0.00128	CcSEcCtD
Gatifloxacin—Hypersensitivity—Methotrexate—muscle cancer	0.00128	0.00128	CcSEcCtD
Gatifloxacin—Asthenia—Methotrexate—muscle cancer	0.00124	0.00124	CcSEcCtD
Gatifloxacin—Feeling abnormal—Doxorubicin—muscle cancer	0.00124	0.00124	CcSEcCtD
Gatifloxacin—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00123	0.00123	CcSEcCtD
Gatifloxacin—Pruritus—Methotrexate—muscle cancer	0.00123	0.00123	CcSEcCtD
Gatifloxacin—Urticaria—Doxorubicin—muscle cancer	0.00119	0.00119	CcSEcCtD
Gatifloxacin—Body temperature increased—Doxorubicin—muscle cancer	0.00119	0.00119	CcSEcCtD
Gatifloxacin—Abdominal pain—Doxorubicin—muscle cancer	0.00119	0.00119	CcSEcCtD
Gatifloxacin—Diarrhoea—Methotrexate—muscle cancer	0.00119	0.00119	CcSEcCtD
Gatifloxacin—Dizziness—Methotrexate—muscle cancer	0.00115	0.00115	CcSEcCtD
Gatifloxacin—Hypersensitivity—Doxorubicin—muscle cancer	0.00111	0.00111	CcSEcCtD
Gatifloxacin—Vomiting—Methotrexate—muscle cancer	0.0011	0.0011	CcSEcCtD
Gatifloxacin—Rash—Methotrexate—muscle cancer	0.00109	0.00109	CcSEcCtD
Gatifloxacin—Dermatitis—Methotrexate—muscle cancer	0.00109	0.00109	CcSEcCtD
Gatifloxacin—Headache—Methotrexate—muscle cancer	0.00109	0.00109	CcSEcCtD
Gatifloxacin—Asthenia—Doxorubicin—muscle cancer	0.00108	0.00108	CcSEcCtD
Gatifloxacin—Pruritus—Doxorubicin—muscle cancer	0.00106	0.00106	CcSEcCtD
Gatifloxacin—Nausea—Methotrexate—muscle cancer	0.00103	0.00103	CcSEcCtD
Gatifloxacin—Diarrhoea—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Gatifloxacin—Dizziness—Doxorubicin—muscle cancer	0.000993	0.000993	CcSEcCtD
Gatifloxacin—Vomiting—Doxorubicin—muscle cancer	0.000955	0.000955	CcSEcCtD
Gatifloxacin—Rash—Doxorubicin—muscle cancer	0.000947	0.000947	CcSEcCtD
Gatifloxacin—Dermatitis—Doxorubicin—muscle cancer	0.000946	0.000946	CcSEcCtD
Gatifloxacin—Headache—Doxorubicin—muscle cancer	0.000941	0.000941	CcSEcCtD
Gatifloxacin—Nausea—Doxorubicin—muscle cancer	0.000892	0.000892	CcSEcCtD
